Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and Ren-2 Transgenic Hypertensive Rats

Š. Jíchová, O. Gawryś, E. Kompanowska-Jezierska, J. Sadowski, V. Melenovský, L. Hošková, L. Červenka, P. Kala, J. Veselka, V. Čertíková Chábová

. 2021 ; 22 (16) : . [pub] 20210806

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025150

Grantová podpora
18-02-00053 Ministerstvo Zdravotnictví Ceské Republiky
68121 Grant Agency of Charles University

The aim of the present study was to perform kidney messenger ribonucleic acid (mRNA) analysis in normotensive, Hannover Sprague-Dawley (HanSD) rats and hypertensive, Ren-2 renin transgenic rats (TGR) after doxorubicin-induced heart failure (HF) with specific focus on genes that are implicated in the pathophysiology of HF-associated cardiorenal syndrome. We found that in both strains renin and angiotensin-converting enzyme mRNA expressions were upregulated indicating that the vasoconstrictor axis of the renin-angiotensin system was activated. We found that pre-proendothelin-1, endothelin-converting enzyme type 1 and endothelin type A receptor mRNA expressions were upregulated in HanSD rats, but not in TGR, suggesting the activation of endothelin system in HanSD rats, but not in TGR. We found that mRNA expression of cytochrome P-450 subfamily 2C23 was downregulated in TGR and not in HanSD rats, suggesting the deficiency in the intrarenal cytochrome P450-dependent pathway of arachidonic acid metabolism in TGR. These results should be the basis for future studies evaluating the pathophysiology of cardiorenal syndrome secondary to chemotherapy-induced HF in order to potentially develop new therapeutic approaches.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025150
003      
CZ-PrNML
005      
20220530150909.0
007      
ta
008      
211013s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms22168475 $2 doi
035    __
$a (PubMed)34445179
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jíchová, Šárka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
245    10
$a Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and Ren-2 Transgenic Hypertensive Rats / $c Š. Jíchová, O. Gawryś, E. Kompanowska-Jezierska, J. Sadowski, V. Melenovský, L. Hošková, L. Červenka, P. Kala, J. Veselka, V. Čertíková Chábová
520    9_
$a The aim of the present study was to perform kidney messenger ribonucleic acid (mRNA) analysis in normotensive, Hannover Sprague-Dawley (HanSD) rats and hypertensive, Ren-2 renin transgenic rats (TGR) after doxorubicin-induced heart failure (HF) with specific focus on genes that are implicated in the pathophysiology of HF-associated cardiorenal syndrome. We found that in both strains renin and angiotensin-converting enzyme mRNA expressions were upregulated indicating that the vasoconstrictor axis of the renin-angiotensin system was activated. We found that pre-proendothelin-1, endothelin-converting enzyme type 1 and endothelin type A receptor mRNA expressions were upregulated in HanSD rats, but not in TGR, suggesting the activation of endothelin system in HanSD rats, but not in TGR. We found that mRNA expression of cytochrome P-450 subfamily 2C23 was downregulated in TGR and not in HanSD rats, suggesting the deficiency in the intrarenal cytochrome P450-dependent pathway of arachidonic acid metabolism in TGR. These results should be the basis for future studies evaluating the pathophysiology of cardiorenal syndrome secondary to chemotherapy-induced HF in order to potentially develop new therapeutic approaches.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorová antibiotika $x škodlivé účinky $7 D000903
650    _2
$a doxorubicin $x škodlivé účinky $7 D004317
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a srdeční selhání $x chemicky indukované $x genetika $x patofyziologie $7 D006333
650    _2
$a hypertenze $x komplikace $x genetika $x patofyziologie $7 D006973
650    _2
$a ledviny $x účinky léků $x patofyziologie $7 D007668
650    _2
$a nemoci ledvin $x chemicky indukované $x genetika $x patofyziologie $7 D007674
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a messenger RNA $x genetika $7 D012333
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a potkani transgenní $7 D055647
650    _2
$a renin $x genetika $7 D012083
650    _2
$a renin-angiotensin systém $x účinky léků $7 D012084
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gawryś, Olga $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, PL02-106 Warsaw, Poland
700    1_
$a Kompanowska-Jezierska, Elżbieta, $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, PL02-106 Warsaw, Poland $d 1959- $7 xx0273376
700    1_
$a Sadowski, Janusz $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, PL02-106 Warsaw, Poland
700    1_
$a Melenovský, Vojtěch $u Department of Cardiology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
700    1_
$a Hošková, Lenka $u Department of Cardiology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
700    1_
$a Červenka, Luděk $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $u Department of Pathophysiology, 2nd Faculty of Medicine, Charles University, 15006 Prague, Czech Republic
700    1_
$a Kala, Petr $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $u Department of Pathophysiology, 2nd Faculty of Medicine, Charles University, 15006 Prague, Czech Republic $u Department of Cardiology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, 15006 Prague, Czech Republic $7 xx0273373
700    1_
$a Veselka, Josef $u Department of Cardiology, University Hospital Motol and 2nd Faculty of Medicine, Charles University, 15006 Prague, Czech Republic
700    1_
$a Čertíková Chábová, Věra $u Department of Nephrology, 1st Faculty of Medicine, Charles University, 12108 Prague, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 16 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34445179 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20220530150907 $b ABA008
999    __
$a ok $b bmc $g 1714273 $s 1145657
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 16 $e 20210806 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 18-02-00053 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a 68121 $p Grant Agency of Charles University
LZP    __
$a Pubmed-20211013
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace